BICO Group Past Earnings Performance
Past criteria checks 0/6
BICO Group's earnings have been declining at an average annual rate of -71.8%, while the Life Sciences industry saw earnings growing at 28.5% annually. Revenues have been growing at an average rate of 40.6% per year.
Key information
-71.8%
Earnings growth rate
-67.4%
EPS growth rate
| Life Sciences Industry Growth | 31.8% |
| Revenue growth rate | 40.6% |
| Return on equity | -61.6% |
| Net Margin | -73.1% |
| Next Earnings Update | 19 Feb 2025 |
Recent past performance updates
Recent updates
Here's Why BICO Group (STO:BICO) Can Afford Some Debt
Jul 01
The Market Doesn't Like What It Sees From BICO Group AB (publ)'s (STO:BICO) Earnings Yet As Shares Tumble 26%
Jun 08Why BICO Group AB (publ) (STO:BICO) Could Be Worth Watching
Dec 02Calculating The Fair Value Of BICO Group AB (publ) (STO:BICO)
May 20Is BICO Group AB (publ) (STO:BICO) Potentially Undervalued?
May 04Is BICO Group (STO:BICO) Using Too Much Debt?
Feb 09Health Check: How Prudently Does BICO Group (STO:BICO) Use Debt?
Oct 24Revenue & Expenses Breakdown
How BICO Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,331 | -1,704 | 1,536 | 74 |
| 30 Jun 24 | 2,423 | -1,498 | 1,532 | 116 |
| 31 Mar 24 | 2,426 | -1,649 | 1,554 | 101 |
| 31 Dec 23 | 2,405 | -1,697 | 1,537 | 0 |
| 30 Sep 23 | 2,213 | -497 | 1,140 | 253 |
| 30 Jun 23 | 2,256 | -390 | 1,380 | 143 |
| 31 Mar 23 | 2,297 | -117 | 1,645 | 67 |
| 31 Dec 22 | 2,327 | -85 | 1,818 | 0 |
| 30 Sep 22 | 2,278 | 41 | 1,857 | 0 |
| 30 Jun 22 | 1,995 | -130 | 1,666 | 0 |
| 31 Mar 22 | 1,743 | -224 | 1,354 | 0 |
| 31 Dec 21 | 1,378 | -228 | 1,061 | 0 |
| 30 Sep 21 | 993 | -188 | 749 | 0 |
| 30 Jun 21 | 744 | -96 | 519 | 0 |
| 31 Mar 21 | 460 | -50 | 342 | 0 |
| 31 Dec 20 | 369 | -36 | 273 | 0 |
| 31 Aug 20 | 236 | -62 | 218 | 0 |
| 31 May 20 | 213 | -49 | 197 | 0 |
| 29 Feb 20 | 197 | -24 | 176 | 0 |
| 30 Nov 19 | 173 | -5 | 138 | 0 |
| 31 Aug 19 | 135 | 1 | 106 | 0 |
| 31 May 19 | 118 | 3 | 87 | 0 |
| 28 Feb 19 | 97 | 4 | 69 | 0 |
| 30 Nov 18 | 76 | 2 | 55 | 0 |
| 31 Aug 18 | 61 | 1 | 43 | 0 |
| 31 May 18 | 45 | 1 | 30 | 0 |
| 28 Feb 18 | 34 | -2 | 24 | 0 |
| 30 Nov 17 | 27 | -2 | 21 | 0 |
| 31 Aug 17 | 20 | -1 | 16 | 0 |
| 31 Aug 16 | 6 | -1 | 4 | 0 |
Quality Earnings: BICO is currently unprofitable.
Growing Profit Margin: BICO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BICO is unprofitable, and losses have increased over the past 5 years at a rate of 71.8% per year.
Accelerating Growth: Unable to compare BICO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BICO is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (36%).
Return on Equity
High ROE: BICO has a negative Return on Equity (-61.62%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/01 23:50 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BICO Group AB (publ) is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dylan van Haaften | Bryan Garnier & Co |
| Hanseung Yoo | Bryan Garnier & Co |
| Maria Vara Fernández | Bryan Garnier & Co |